2007
DOI: 10.1007/s10856-007-3214-3
|View full text |Cite
|
Sign up to set email alerts
|

Fabrication of HA/PHBV composite scaffolds through the emulsion freezing/freeze-drying process and characterisation of the scaffolds

Abstract: Biodegradable polymer-based scaffolds containing osteoconductive hydroxyapatite (HA) particles can be very useful for bone tissue engineering. In this investigation, HA nanoparticles were incorporated in poly(hydroxybutyrate-co-valerate) (PHBV) polymer to fabricate osteoconductive composite scaffolds. PHBV and HA/PHBV scaffolds were made using an emulsion freezing/freeze-drying technique. The scaffolds produced were subsequently characterized using several techniques. It was found that the scaffolds were highl… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

2
93
0

Year Published

2010
2010
2017
2017

Publication Types

Select...
5
5

Relationship

1
9

Authors

Journals

citations
Cited by 147 publications
(95 citation statements)
references
References 15 publications
2
93
0
Order By: Relevance
“…The obtained n value was 0.417, which is close to the characteristic n value for Fickian diffusion (i.e., 0.43 for sphere), indicating a diffusion controlled release mechanism. The components (PBS and ethanol) of the release medium used in this work are non-solvents of PHBV, therefore, the shrinkage or swelling of the polymer is negligible, 36 which results in a diffusion controlled drug release behavior, as discussed elsewhere.…”
Section: Daidzein Release Profilesmentioning
confidence: 99%
“…The obtained n value was 0.417, which is close to the characteristic n value for Fickian diffusion (i.e., 0.43 for sphere), indicating a diffusion controlled release mechanism. The components (PBS and ethanol) of the release medium used in this work are non-solvents of PHBV, therefore, the shrinkage or swelling of the polymer is negligible, 36 which results in a diffusion controlled drug release behavior, as discussed elsewhere.…”
Section: Daidzein Release Profilesmentioning
confidence: 99%
“…Hence, nHA is usually combined with biopolymer and organic material into a composite form to overcome the limitations of its mechanical properties. Many studies have been reported on the fabrication of composite scaffolds using nHA with biocompatible polymers, such as poly-L-lactic acid (PLLA) (Davachi et al 2016), poly-L-glycolic acid (PLGA) (Zheng et al 2013), poly(hydroxybutyrate-co-valerate) (PHBV) (Sultana and Wang 2008), cellulose (Zadegan et al 2011), PCL (Hassan et al 2014), and polyvinyl alcohol (PVA) (Sultana and Zainal 2016).…”
Section: Introductionmentioning
confidence: 99%
“…In recent decades a variety of bone scaffold manufacturing techniques have been developed in an effort to address these limitations. Using ceramics, polymers or combinations of the two, solvent casting and particulate leaching [2], gas foaming [3], fibre meshes and fibre bonding [4], phase separation [2], melt moulding [5], emulsion freeze drying [6], solution casting [7], freeze drying [4], fused deposition modelling [8], rapid prototyping [9], membrane lamination [10], microsphere sintering [2], supercritical fluid technology [11] and various preform replication techniques [12][13][14][15][16][17][18][19][20][21][22] have all been employed to produce scaffolds with variable pore size, porosity and connectivity.…”
Section: Introductionmentioning
confidence: 99%